Research indicates that lifestyle choices significantly outweigh genetic predispositions in determining health outcomes. A ...

Cardiovascular disease (CVD) is responsible for up to 25% of premature deaths in the UK, 80% of which are preventable. We explore the role integrated care systems could play in scaling up the ...

Positive high-level results from the BaxHTN Phase III trial showed baxdrostat at two doses (2mg and 1mg) demonstrated a statistically significant and clinically meaningful reduction in mean seated ...

SGLT2 inhibitors reduced heart failure events and cardiovascular death in patients with heart failure, type 2 diabetes, chronic kidney disease, and atherosclerotic cardiovascular disease. These ...